What type of study is this?

This is a Systematic Review study.

September 5, 2025CureusOpen Access

Effectiveness of Beta-Blockers in Reducing Mortality and Recurrence After Myocardial Infarction: A Systematic Review of Contemporary and Foundational Evidence

View Full Paper

Ask AI

Bookmark

Authors

Systematic review shows beta-blockers reduce mortality and recurrent MI in adults post-myocardial infarction, suggesting improved care protocols.

Beta-blockers significantly reduce all-cause mortality by 23-26% and recurrent MI by up to 41% following myocardial infarction.
Evidence includes four studies, combining two randomized controlled trials, an observational study, and a post hoc analysis with 19,078 participants.
Findings support the relevance of beta-blockers in clinical guidelines, indicating their effectiveness across diverse patient profiles.
Individualized treatment approaches are recommended due to heterogeneity in populations and study designs.

Popraya et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Systematic review shows beta-blockers reduce mortality and recurrent MI in adults post-myocardial infarction, suggesting improved care protocols.